Bayview Legacy, LLC filed a Form 4 with the SEC on September 3, 2026, disclosing the sale of 100,000 shares of Arteris, Inc. common stock on September 1, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Shares sold: 100,000 shares of Arteris, Inc. common stock disposed of on September 1, 2026.
  • Weighted average price: $20.7497 per share, with individual transaction prices ranging from $20.465 to $21.410 inclusive.
  • Remaining beneficial ownership: 8,229,071 shares held indirectly following the reported transaction.
  • Trading plan: The sale was made pursuant to a Rule 10b5-1 plan adopted by K. Charles Janac, as manager of Bayview Legacy, LLC, on December 12, 2025.
  • Reporting person role: Bayview Legacy, LLC is identified as a 10% owner of Arteris, Inc. (NASDAQ:AIP).

Bayview Legacy LLC Share Sale Details for Arteris, Inc.

According to the Form 4 filed on September 3, 2026, Bayview Legacy, LLC, a 10% owner of Arteris, Inc. (NASDAQ:AIP), disposed of 100,000 shares of common stock on September 1, 2026. The filing indicates the transaction was executed under a Rule 10b5-1 trading plan adopted by K. Charles Janac, in his capacity as manager of Bayview Legacy, LLC, on December 12, 2025. The transaction code recorded is "S," indicating a sale.

The filing reports a weighted average sale price of $20.7497 per share. According to the footnotes, the shares were sold in multiple transactions at prices ranging from $20.465 to $21.410 inclusive. The filing states that the reporting person will provide full information on the number of shares sold at each separate price within that range upon request by the issuer, any security holder, or SEC staff.

Following the reported sale, Bayview Legacy, LLC beneficially owns 8,229,071 shares of Arteris, Inc. common stock, held indirectly. The filing notes that K. Charles Janac, as manager of Bayview Legacy, LLC, is deemed to have voting and dispositive power over the shares owned by the entity. The filing also discloses that K. Charles Janac separately filed a Form 4 on the same date reporting the same transaction in his individual capacity, given his beneficial ownership of the security through Bayview Legacy, LLC.

What Was Disclosed

Bayview Legacy, LLC reported the sale of 100,000 shares of Arteris, Inc. common stock at a weighted average price of $20.7497, executed under a pre-established Rule 10b5-1 plan, leaving the entity with 8,229,071 shares beneficially owned indirectly.